The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 18, 2008
Filed:
Apr. 25, 2006
Christopher Todd Bauer, St. Louis, MO (US);
Maureen Jeri Bourner, Defiance, MO (US);
Melanie Boyle, Granta Park, GB;
Gerald Fries Casperson, Ballwin, MO (US);
David William Griggs, Ballwin, MO (US);
Richard David Head, O'Fallon, MO (US);
William Dean Joy, St. Louis, MO (US);
Richard Allen Mazzarella, Webster Groves, MO (US);
Ralph Raymond Minter, Cambridge, GB;
Mark Allen Moffat, St. Louis, MO (US);
Barrett Richard Thiele, St. Louis, MO (US);
Todd Lee Vanarsdale, Carlsbad, CA (US);
Christopher Todd Bauer, St. Louis, MO (US);
Maureen Jeri Bourner, Defiance, MO (US);
Melanie Boyle, Granta Park, GB;
Gerald Fries Casperson, Ballwin, MO (US);
David William Griggs, Ballwin, MO (US);
Richard David Head, O'Fallon, MO (US);
William Dean Joy, St. Louis, MO (US);
Richard Allen Mazzarella, Webster Groves, MO (US);
Ralph Raymond Minter, Cambridge, GB;
Mark Allen Moffat, St. Louis, MO (US);
Barrett Richard Thiele, St. Louis, MO (US);
Todd Lee Vanarsdale, Carlsbad, CA (US);
Agouron Pharmaceuticals, Inc., San Diego, CA (US);
Abstract
The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that bind to P-cadherin, and that function to inhibit P-cadherin. The invention also relates to heavy and light chain immunoglobulins derived from human P-cadherin antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human P-cadherin antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the present invention.